An Investigation Into the Feasibility of Beetroot Juice Supplementation in People Living With Alzheimer's Disease.
NCT07258004 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2025-12-02
Summary
The goal of this clinical trial is to learn if taking a beetroot juice supplement will work in people living with Alzheimer's disease. The main questions it aims to answer are:
* Can people living with Alzheimer's disease realistically drink beetroot juice regularly (for example, is it easy to take, free from side effects and acceptable)?
* Does drinking beetroot juice twice a day improve health in people living with Alzheimer's disease?
Researchers will look at how you managed with the beetroot juice, as well as if there were any improvements in your health measures.
Participants will:
* Complete testing before and after the intervention for no more than 3 hours each time
* Complete a 1-day food diary before testing
* Take a beetroot juice supplementation twice daily for 1-week
* Keep a note of any problems with the beetroot juice
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Beetroot juice
Participants will take a concentrated beetroot juice shot (70ml) twice daily for 1-week. Each shot contains 400mg of dietary nitrate (800mg per day).
Sponsors & Collaborators
-
NHS Lanarkshire
collaborator OTHER_GOV -
University of the West of Scotland
lead OTHER
Principal Investigators
-
Rachel Kimble · University of the West of Scotland
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 65 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-31
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)
NCT06402838 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Investigator Initiated Trial of Galcanezumab Treatment in Alzheimer's Disease
NCT07323927 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Medium Chain Triglyceride Intervention for Patients With Alzheimer Disease
NCT02912936 ·Status: COMPLETED ·Phase: NA
-
Effect of PF-04360365 On ABETA In Patients With Alzheimer's Disease And Healthy Volunteers
NCT01005862 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
NCT06976216 ·Status: RECRUITING ·Phase: PHASE3
-
A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease
NCT00164749 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Open Label Study of TRx0014 in Alzheimer's Disease
NCT00684944 ·Status: COMPLETED ·Phase: PHASE2
-
RQC for the Prevention of Alzheimer's Disease and Retinal Amyloid-β
NCT06470061 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Comparative Bioavailability in Healthy Elderly Volunteers
NCT01253122 ·Status: COMPLETED ·Phase: PHASE1
-
Creatine to Augment Bioenergetics in Alzheimer's
NCT05383833 ·Status: COMPLETED ·Phase: NA
-
Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease
NCT02035982 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Target Engagement of Centella Asiatica in Cognitive Impairment
NCT05591027 ·Status: RECRUITING ·Phase: PHASE1
-
Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive Impairment
NCT02573740 ·Status: TERMINATED ·Phase: PHASE1
-
A Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease
NCT01320527 ·Status: COMPLETED ·Phase: PHASE2
-
Exploration of the Efficacy and Mechanisms of Lymphaticovenous Anastomosis in the Treatment of Alzheimer's Disease
NCT06706947 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy and Safety of Curcumin Formulation in Alzheimer's Disease
NCT01001637 ·Status: TERMINATED ·Phase: NA
-
Anti-Oxidant Treatment of Alzheimer's Disease
NCT00117403 ·Status: COMPLETED ·Phase: PHASE1
-
Ginkgo Biloba Prevention Trial in Older Individuals
NCT00010803 ·Status: COMPLETED ·Phase: PHASE3
-
CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease
NCT02021682 ·Status: COMPLETED
-
Safety Study of Nicotinamide to Treat Alzheimer's Disease
NCT00580931 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
NCT02245568 ·Status: TERMINATED ·Phase: PHASE3
-
Curcumin in Patients With Mild to Moderate Alzheimer's Disease
NCT00099710 ·Status: COMPLETED ·Phase: PHASE2
-
Lomecel-B Infusion Versus Placebo in Patients With Alzheimer's Disease
NCT02600130 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation the Effect of Acetyl-L-carnitine in Patients With Mild Cognitive Impairment Accompanied With Chronic Cerebrovascular Disease
NCT04346862 ·Status: UNKNOWN ·Phase: PHASE4
-
Sleep Trial to Prevent Alzheimer's Disease
NCT04629547 ·Status: RECRUITING ·Phase: PHASE2